Nurandociguat clinical trials
Also written BAY3283142.
Its developmentBy Bayer, step by step9 company-led studies, furthest phase 2: when each phase was reached, its deals, target and what is ahead.How each study uses nurandociguat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the nurandociguat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2024 (4); 1 more planned to start later
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 1 |
Who runs them
Industry 8 · Other 0
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test nurandociguat.
Studies
Open first, then newest update. How each study uses nurandociguat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery DiseaseNot yet recruitingPhase 1BayerNCT07431294Written as Nurandociguat
- A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the BodyCompletedPhase 1BayerNCT07722585Written as Nurandociguat (BAY3283142) old tablet - SD
- A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood PressureCompletedPhase 1BayerNCT06428825Written as BAY3283142
- A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney DiseaseCompletedPhase 2BayerNCT06522997Written as BAY3283142
- A Study to Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver FunctionCompletedPhase 1BayerNCT06402721Written as BAY3283142
- A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese ParticipantsCompletedPhase 1BayerNCT06487845Written as BAY3283142
- A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male ParticipantsCompletedPhase 1BayerNCT05800444Written as BAY3283142
- A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple DosesCompletedPhase 1BayerNCT05491642Written as BAY3283142
Given beside what is tested · 1 — nurandociguat is usual care or a partner of the new treatment
Codes
What other systems call nurandociguat · ClinicalTrials.gg INT017204
- UNII (FDA) LPU8429UK5NURANDOCIGUATOne source FDA
- NCI Thesaurus C206950NurandociguatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | LPU8429UK5 | NURANDOCIGUAT | One source FDA |
| NCI Thesaurus | C206950 | Nurandociguat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.